Showing results (491-500 of 2,352) with videos related to

Sort By:
Pageof 236
Dental Traumatology : Official Publication of International Association for Dental Traumatology|September 7, 2017
Management of an uncomplicated crown fracture by reattaching the fractured fragment-Case reportJosué Martos, Karoline V A Pinto, Tiago M F Miguelis, et al.
British Journal of Pharmacology|December 1, 1996
Effects of adrenomedullin and calcitonin gene-related peptide on airway and pulmonary vascular smooth muscle in guinea-pigsA Pinto, K Sekizawa, M Yamaya, et al.
Leukemia & Lymphoma|February 1, 1997
CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissuesH J Gruss, F Herrmann, V Gattei, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 17, 2009
Laparoscopy for recurrent Crohn's disease: how do the results compare with the results for primary Crohn's disease?R A Pinto, S Shawki, K Narita, et al.
Microbiology (Reading, England)|October 17, 2017
Ultrastructural and microbial analyses of cellulose degradation in leaf-cutter ant coloniesRolando Daniel Moreira-Soto, Ethel Sanchez, Cameron R Currie, et al.
The Quarterly Journal of Medicine|January 1, 1984
The problem of cytomegalovirus infection in renal allograft recipientsJ B Kurtz, J F Thompson, A Ting, et al.
Supportive Cancer Therapy|July 17, 2008
Benefits of GM-CSF Versus Placebo or G-CSF in Reducing Chemotherapy-Induced Complications: A Systematic Review of the LiteratureRobert W Dubois, Lionel A Pinto, Myriam Bernal, et al.
Journal of Autism and Developmental Disorders|December 13, 2006
Disparities in diagnoses received prior to a diagnosis of autism spectrum disorderDavid S Mandell, Richard F Ittenbach, Susan E Levy, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1990
Acridine orange--RNA histofluorescence of sarcomas and small round cell tumors of childhoodA Pinto, H B Sarnat, C Vogler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2006
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot studyG Corazzelli, F Russo, G Capobianco, et al.
Pageof 236